NCT06636149 Maternal Maneuvers During Prolonged Labor
| NCT ID | NCT06636149 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Labor Stage, First |
| Study Type | INTERVENTIONAL |
| Enrollment | 82 participants |
| Start Date | 2024-12-10 |
| Primary Completion | 2028-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 82 participants in total. It began in 2024-12-10 with a primary completion date of 2028-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot, randomized control trial will test whether or not a specific circuit of position changes improves maternal outcomes in cases of prolonged labor. Patient who have prolonged labor will be approached for consent and randomization to one of two study groups: circuit intervention against routine standard of care position changes. 82 patients will be enrolled in the study. Exclusion criteria will include: any uterine infection prior to randomization, magnesium sulfate treatment, major fetal anomalies, BMI ≥50, non-reassuring fetal status prior to randomization, or any maternal diagnosis that precludes safety or feasibility of the circuit of maternal position changes. The 3 aims of the study will include: the outcome that the circuit of position changes has on the duration of the first stage of labor, maternal and neonatal morbidity, and maternal satisfaction.
Eligibility Criteria
Inclusion Criteria: * English-speaking patients * Singleton, vertex pregnancies * 34 weeks' gestation or later * Admitted to Labor and Delivery in spontaneous labor or for an induction of labor * Prolonged labor course as defined by: cervical dilation less than 6 cm after 8 hours or more of ruptured membranes (spontaneous or artificial) and oxytocin infusion, or cervical dilation 6 cm or more and less than 1-cm cervical dilation change over 2 hours or more with ruptured membranes and oxytocin infusion Exclusion Criteria: * Intraamniotic infection prior to randomization * Magnesium sulfate treatment * Major fetal anomalies * BMI ≥50 * Non-reassuring fetal status prior to randomization * Any maternal diagnosis that precludes safety or feasibility of intrapartum circuit of maternal position changes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06636149 clinical trial?
This trial is open to female participants only, aged 12 Years or older, studying Labor Stage, First. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06636149 currently recruiting?
Yes, NCT06636149 is actively recruiting participants. Contact the research team at hebaker@wustl.edu for enrollment information.
Where is the NCT06636149 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT06636149 clinical trial?
NCT06636149 is sponsored by Washington University School of Medicine. The trial plans to enroll 82 participants.